Table 1

Absorption of anti-PCNA with PCNA

Patients		Anti-PCNA after absorption with PCNA (OD)		Per cent binding inhibition
Patients		0 μg	0.1 μg	Per cent binding inhibition		0.5 μg	1 μg	3 μg	6 μg
HBV
8	1.473	0.953	0.547	0.629	0.423	0.499	71.3
50	2.290	1.546	0.498	1.043	0.470	0.658	79.5
51	3.142	1.393	0.699	1.462	1.011	0.514	77.8
103	3.151	0.873	0.604	0.880	0.759	0	80.8
113	4.100	1.651	1.437	1.936	1.229	0.395	90.4

HCV
46	2.082	1.349	1.427	1.112	0.751	0.322	84.5
55	3.233	2.896	1.292	2.375	1.955	0.607	81.7
78	1.798	0.985	0.158	0.355	0.458	0.193	89.3
SLE	3.729	2.914	1.668	1.672	1.096	0.858	77.0